Absci (ABSI) Research & Development (2020 - 2026)

Absci has reported Research & Development for 7 years, with the latest figure at $19.3 million in Q1 2026.

• Quarterly Research & Development rose 17.79% year-over-year to $19.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84.3 million (up 24.04% YoY) and the FY2025 annual result came in at $81.4 million, up 27.5% from the prior year.
• Research & Development declined to $19.3 million in Q1 2026 per ABSI's latest filing, from $25.3 million in the prior quarter.
• Over five years, Research & Development peaked at $25.3 million in Q4 2025 and troughed at $11.0 million in Q3 2023.
• A 5-year average of $16.0 million and a median of $15.8 million in 2022 frame the typical range for Research & Development.
• The sharpest annual moves came in 2022 and 2023: Research & Development soared 124.5% in 2022, then dropped 28.96% in 2023.
• Over 5 years, Research & Development stood at $11.3 million in 2022, then climbed by 8.43% to $12.3 million in 2023, then soared by 49.78% to $18.4 million in 2024, then soared by 37.93% to $25.3 million in 2025, then declined by 23.96% to $19.3 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $19.3 million, $25.3 million, and $19.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.